Vivani Medical VANI Biopharm Division — Professional Services And Insurance Expense

Similar metrics at other companies

PFEBiopharma — Selling, informational and administrative expenses

$2.13B-2.5%

SGPReporting Segment — Professional fees

$1.56M+312%

CBUInsurance Services — Professional Fees

$79K-21.0%

AMP

AMPHPharmaceutical Products — Consulting And Outside Services Expense

$10.36M+8.1%

FRHCInsurance — Professional services

$630K+110%

LHBiopharma Laboratory Services — Other Cost and Expense, Operating

$89.7M-0.3%

Questions, answered.

What is Vivani Medical's biopharm division — professional services and insurance expense?

Vivani Medical (VANI) reported biopharm division — professional services and insurance expense of $1.06M in Q1 2026.

How has Vivani Medical's biopharm division — professional services and insurance expense changed year-over-year?

Vivani Medical's biopharm division — professional services and insurance expense decreased by 19.7% year-over-year, from $1.32M to $1.06M.

What is the long-term trend for Vivani Medical's biopharm division — professional services and insurance expense?

Over 2 years (2023 to 2025), Vivani Medical's biopharm division — professional services and insurance expense has grown at a 8.8% compound annual growth rate (CAGR), from $4.15M to $4.91M.

What does biopharm division — professional services and insurance expense mean?

Covers external costs for legal, consulting, regulatory, and insurance services specifically allocated to the biopharmaceutical segment. These expenses are necessary to manage corporate governance, intellectual property protection, and risk mitigation. Monitoring these costs helps assess the segment's administrative overhead and external support requirements.